K. Syrjäkoski

发表

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

O. Kallioniemi, J. Kononen, H. Nevanlinna, 2002, American journal of human genetics.

Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus.

E. Gillanders, D. Stephan, H. Grönberg, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

J. Hopper, D. Easton, P. Pharoah, 2003, American journal of human genetics.

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

Nazneen Rahman, Michael Bremer, Julian Peto, 2004, American journal of human genetics.

Androgen Receptor Gene Alterations in Finnish Male Breast Cancer

A. Auvinen, O. Kallioniemi, P. Koivisto, 2004, Breast Cancer Research and Treatment.

Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study.

T. Lehtimäki, M. Perola, K. Syrjäkoski, 2002, Atherosclerosis.

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland

Jaana M. Hartikainen, J. Kere, E. Gillanders, 2000, European Journal of Human Genetics.

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

J. Schleutker, T. Tammela, O. Kallioniemi, 2001, British Journal of Cancer.

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

O. Kallioniemi, H. Nevanlinna, H. Eerola, 2001, British Journal of Cancer.

Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients

J. Schleutker, T. Tammela, T. Ikonen, 2006, International journal of cancer.

Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis

J. Kononen, K. Syrjäkoski, H. Haapasalo, 1999, The Journal of pathology.

Response: Re: Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

O. Kallioniemi, H. Nevanlinna, H. Eerola, 2001 .

Mutations in the BRCA2 interacting DSS1 are not a risk factor for male breast cancer

A. Kallioniemi, K. Syrjäkoski, R. Karhu, 2007, International journal of cancer.

Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.

J. Schleutker, T. Tammela, O. Kallioniemi, 2000, Cancer research.

NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer

Päivi Heikkilä, Jiri Bartek, Arto Mannermaa, 2008, Nature Genetics.

Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.

K Holli, O. Kallioniemi, H. Nevanlinna, 2000, Journal of the National Cancer Institute.

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.

O. Kallioniemi, B. Ward, H. Nevanlinna, 1997, Human molecular genetics.

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

Päivi Heikkilä, Jiri Bartek, Heli Nevanlinna, 2005, International journal of cancer.

A recurrent mutation in PALB2 in Finnish cancer families

Katri Pylkäs, Arja Jukkola-Vuorinen, Mervi Grip, 2007, Nature.

BRCA2 mutations in 154 finnish male breast cancer patients.

Anssi Auvinen, A. Auvinen, K. Waltering, 2004, Neoplasia.

BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition

Heli Nevanlinna, Kristiina Aittomäki, Carl Blomqvist, 2006, European Journal of Human Genetics.

Frequent amplification and overexpression of CCND1 in male breast cancer

A. Auvinen, A. Kallioniemi, K. Syrjäkoski, 2004, International journal of cancer.

Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families

J. Kere, O. Kallioniemi, R. Barkardottir, 2001, European Journal of Human Genetics.

CHEK2 variant I157T may be associated with increased breast cancer risk

Päivi Heikkilä, Jiri Bartek, Heli Nevanlinna, 2004, International journal of cancer.

Genetic Predisposition to Male and Female Breast Cancer

K. Syrjäkoski, K. Syrjäkoski, 2004 .

Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies

J. Kere, L. Aaltonen, P. Møller, 2006, Journal of Medical Genetics.

BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland

J. Schleutker, T. Tammela, O. Kallioniemi, 2003, Journal of medical genetics.

Large genomic BRCA 2 rearrangements and male breast cancer

A. Kallioniemi, K. Syrjäkoski, R. Karhu, 2006 .

Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.

J. Kere, N. Waddell, O. Kallioniemi, 2006, Carcinogenesis.

Large genomic BRCA2 rearrangements and male breast cancer.

A. Kallioniemi, K. Syrjäkoski, R. Karhu, 2006, Cancer detection and prevention.

Search for large genomic alterations of the BRCA1 gene in a Finnish population.

A. Kallioniemi, K. Syrjäkoski, K. Holli, 2005, Cancer genetics and cytogenetics.

Penetrance Analysis of the PALB2 c.1592delT Founder Mutation

J. Hopper, M. Southey, A. Mannermaa, 2008, Clinical Cancer Research.

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

D. Easton, J. Hopper, D. Easton, 2005, Journal of Medical Genetics.

Analysis of p53 Tumor Suppressor Gene in Families with Multiple Glioma Patients

J. Isola, M. Matikainen, K. Syrjäkoski, 2001, Journal of Neuro-Oncology.

CHEK2 1100delC is not a risk factor for male breast cancer population

A. Auvinen, O. Kallioniemi, K. Syrjäkoski, 2004, International journal of cancer.

ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer

Joan E Bailey-Wilson, Heli Nevanlinna, Rainer Fagerholm, 2008, European Journal of Human Genetics.

Matrix metalloproteinase3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques.

T. Lehtimäki, M. Perola, K. Syrjäkoski, 2005, Atherosclerosis.